S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
146 Pounds of Graphite Needed for Each EV (Ad)
Is Frontline's 20% Dividend Too Good To Be True?
3 Reasons The Wayfair Rally Is Way Overdone
146 Pounds of Graphite Needed for Each EV (Ad)
Wheat prices jump following collapse of major dam in southern Ukraine
Here’s What’s Driving the Price of Carvana Higher
The $193 Billion US-China War You Don't Know About (Ad)
Stock market today: World stocks mixed as Wall St inches toward bull market
Tesla: How and Why It Gets To $300
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
146 Pounds of Graphite Needed for Each EV (Ad)
Is Frontline's 20% Dividend Too Good To Be True?
3 Reasons The Wayfair Rally Is Way Overdone
146 Pounds of Graphite Needed for Each EV (Ad)
Wheat prices jump following collapse of major dam in southern Ukraine
Here’s What’s Driving the Price of Carvana Higher
The $193 Billion US-China War You Don't Know About (Ad)
Stock market today: World stocks mixed as Wall St inches toward bull market
Tesla: How and Why It Gets To $300
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
146 Pounds of Graphite Needed for Each EV (Ad)
Is Frontline's 20% Dividend Too Good To Be True?
3 Reasons The Wayfair Rally Is Way Overdone
146 Pounds of Graphite Needed for Each EV (Ad)
Wheat prices jump following collapse of major dam in southern Ukraine
Here’s What’s Driving the Price of Carvana Higher
The $193 Billion US-China War You Don't Know About (Ad)
Stock market today: World stocks mixed as Wall St inches toward bull market
Tesla: How and Why It Gets To $300
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
146 Pounds of Graphite Needed for Each EV (Ad)
Is Frontline's 20% Dividend Too Good To Be True?
3 Reasons The Wayfair Rally Is Way Overdone
146 Pounds of Graphite Needed for Each EV (Ad)
Wheat prices jump following collapse of major dam in southern Ukraine
Here’s What’s Driving the Price of Carvana Higher
The $193 Billion US-China War You Don't Know About (Ad)
Stock market today: World stocks mixed as Wall St inches toward bull market
Tesla: How and Why It Gets To $300
NASDAQ:ISPC

iSpecimen (ISPC) Stock Forecast, Price & News

$1.48
+0.21 (+16.54%)
(As of 06/6/2023 ET)
Compare
Today's Range
$1.31
▼
$1.50
50-Day Range
$1.22
▼
$1.88
52-Week Range
$1.17
▼
$3.26
Volume
23,786 shs
Average Volume
31,406 shs
Market Capitalization
$13.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.63
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

iSpecimen MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
415.2% Upside
$7.63 Price Target
Short Interest
Healthy
0.53% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$5,500 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.60 out of 5 stars

Medical Sector

93rd out of 982 stocks

Commercial Physical Research Industry

3rd out of 16 stocks

See Top Rated MarketRank™ Stocks Here

ISPC stock logo

About iSpecimen (NASDAQ:ISPC) Stock

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

Receive ISPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter.

ISPC Stock News Headlines

May 23, 2023 | finance.yahoo.com
iSpecimen to Participate in Maxim’s Healthcare IT Virtual Conference on June 1, 2023
May 18, 2023 | msn.com
Looking Into iSpecimen's Return On Capital Employed
June 7, 2023 | Edge On The Street (Ad)
146 Pounds of Graphite Needed for Each EV
Graphite - not lithium - is the largest component of lithium-ion batteries used in electric vehicles. That's why 97 more graphite mines will be needed by 2035 just to keep up with battery demand for the $7 trillion EV market.
May 4, 2023 | finance.yahoo.com
iSpecimen Reports First Quarter 2023 Results
April 24, 2023 | finance.yahoo.com
iSpecimen to Participate in the Aegis Virtual Conference on May 4, 2023
April 20, 2023 | finance.yahoo.com
iSpecimen to Report First Quarter 2023 Results on May 4, 2023
April 19, 2023 | americanbankingnews.com
Contrasting iSpecimen (ISPC) and Its Rivals
April 18, 2023 | finance.yahoo.com
Market Might Still Lack Some Conviction On iSpecimen Inc. (NASDAQ:ISPC) Even After 33% Share Price Boost
June 7, 2023 | Edge On The Street (Ad)
146 Pounds of Graphite Needed for Each EV
Graphite - not lithium - is the largest component of lithium-ion batteries used in electric vehicles. That's why 97 more graphite mines will be needed by 2035 just to keep up with battery demand for the $7 trillion EV market.
April 18, 2023 | americanbankingnews.com
iSpecimen (ISPC) and Its Rivals Head-To-Head Analysis
April 18, 2023 | americanbankingnews.com
Contrasting iSpecimen (ISPC) & Its Peers
April 17, 2023 | americanbankingnews.com
Reviewing iSpecimen (ISPC) and The Competition
April 16, 2023 | americanbankingnews.com
Financial Analysis: iSpecimen (ISPC) versus Its Peers
April 16, 2023 | americanbankingnews.com
Contrasting iSpecimen (NASDAQ:ISPC) & bioAffinity Technologies (NASDAQ:BIAF)
April 15, 2023 | americanbankingnews.com
iSpecimen (ISPC) vs. Its Competitors Head-To-Head Comparison
April 15, 2023 | americanbankingnews.com
iSpecimen (ISPC) and Its Competitors Financial Survey
April 14, 2023 | americanbankingnews.com
iSpecimen (ISPC) vs. Its Competitors Financial Contrast
April 12, 2023 | americanbankingnews.com
Critical Review: iSpecimen (ISPC) and Its Peers
April 12, 2023 | americanbankingnews.com
Head-To-Head Review: iSpecimen (ISPC) and Its Competitors
April 11, 2023 | americanbankingnews.com
iSpecimen (ISPC) versus Its Rivals Head to Head Survey
April 11, 2023 | americanbankingnews.com
Financial Survey: iSpecimen (ISPC) and Its Peers
April 11, 2023 | americanbankingnews.com
Head-To-Head Survey: iSpecimen (ISPC) & The Competition
April 10, 2023 | americanbankingnews.com
iSpecimen (ISPC) & Its Competitors Critical Comparison
April 10, 2023 | americanbankingnews.com
Contrasting iSpecimen (ISPC) & The Competition
April 8, 2023 | americanbankingnews.com
iSpecimen (ISPC) & Its Rivals Head to Head Contrast
April 8, 2023 | americanbankingnews.com
Financial Review: iSpecimen (ISPC) vs. Its Peers
April 7, 2023 | americanbankingnews.com
Analyzing iSpecimen (ISPC) and Its Peers
See More Headlines

ISPC Price History

ISPC Company Calendar

Last Earnings
3/14/2023
Today
6/06/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ISPC
CUSIP
N/A
CIK
1558569
Web
ispecimen.com
Phone
781-301-6700
Fax
N/A
Employees
59
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.63
High Stock Price Forecast
$11.00
Low Stock Price Forecast
$4.25
Forecasted Upside/Downside
+415.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($1.16)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-10,250,000.00
Net Margins
-95.03%
Pretax Margin
-95.02%
Return on Equity
-47.82%
Return on Assets
-39.26%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.14
Quick Ratio
4.14

Sales & Book Value

Annual Sales
$10.40 million
Price / Sales
1.29
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.32 per share
Price / Book
0.64

Miscellaneous

Outstanding Shares
9,030,000
Free Float
6,077,000
Market Cap
$13.36 million
Optionable
Not Optionable
Beta
1.93

Key Executives

  • Ms. Tracy Wilson Curley (Age 60)
    CFO, Treasurer & Interim CEO
    Comp: $367k
  • Dr. Christopher J. Ianelli M.D. (Age 54)
    Ph.D., Founder & Director
    Comp: $440k
  • Mr. Benjamin Bielak (Age 52)
    Chief Information Officer
    Comp: $334k
  • Ms. Jill Mullan (Age 57)
    Sec. & Director
    Comp: $391.25k
  • Ms. Dawn Michelle
    VP of Operations
  • Mr. Eric Langlois
    Sr. VP of Sales & Bus. Devel.
  • Ms. Carly Lejnieks
    VP of Marketing
  • Ms. Emily Hubbard
    VP of Site Management & Devel.
  • Mr. David Wages M.D.
    Ph.D., Chief Medical Officer

Key Competitors

View All Competitors

Insiders

View All Insider Transactions













ISPC Stock - Frequently Asked Questions

Should I buy or sell iSpecimen stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for iSpecimen in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" ISPC shares.
View ISPC analyst ratings or view top-rated stocks.

What is iSpecimen's stock price forecast for 2023?

1 analysts have issued 12-month target prices for iSpecimen's shares. Their ISPC share price forecasts range from $4.25 to $11.00. On average, they expect the company's stock price to reach $7.63 in the next year. This suggests a possible upside of 415.2% from the stock's current price.
View analysts price targets for ISPC or view top-rated stocks among Wall Street analysts.

How have ISPC shares performed in 2023?

iSpecimen's stock was trading at $1.3750 at the beginning of 2023. Since then, ISPC stock has increased by 7.6% and is now trading at $1.48.
View the best growth stocks for 2023 here.

Are investors shorting iSpecimen?

iSpecimen saw a decline in short interest in May. As of May 15th, there was short interest totaling 28,100 shares, a decline of 43.0% from the April 30th total of 49,300 shares. Based on an average daily trading volume, of 30,900 shares, the short-interest ratio is presently 0.9 days. Currently, 0.5% of the company's shares are sold short.
View iSpecimen's Short Interest.

When is iSpecimen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our ISPC earnings forecast.

How were iSpecimen's earnings last quarter?

iSpecimen Inc. (NASDAQ:ISPC) announced its quarterly earnings data on Tuesday, March, 14th. The company reported ($0.24) earnings per share for the quarter. The firm had revenue of $2.96 million for the quarter. iSpecimen had a negative net margin of 95.03% and a negative trailing twelve-month return on equity of 47.82%.

When did iSpecimen IPO?

(ISPC) raised $20 million in an IPO on Thursday, June 17th 2021. The company issued 2,200,000 shares at $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) served as the underwriter for the IPO.

What is iSpecimen's stock symbol?

iSpecimen trades on the NASDAQ under the ticker symbol "ISPC."

How do I buy shares of iSpecimen?

Shares of ISPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iSpecimen's stock price today?

One share of ISPC stock can currently be purchased for approximately $1.48.

How much money does iSpecimen make?

iSpecimen (NASDAQ:ISPC) has a market capitalization of $13.36 million and generates $10.40 million in revenue each year. The company earns $-10,250,000.00 in net income (profit) each year or ($1.16) on an earnings per share basis.

How can I contact iSpecimen?

The official website for the company is ispecimen.com. The company can be reached via phone at 781-301-6700 or via email at ispecimen@kcsa.com.

This page (NASDAQ:ISPC) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -